APA (7th ed.) Citation

Kocab, A. J., Cano, M., Bacellar-Galdino, M., Jamison, J. A., Brock, W. J., Zacks, D. N., & Handa, J. T. (2025, August). In Vivo Characterization of ONL1204, a Small Peptide Inhibitor of the Fas Receptor, as a Potential Neuroprotective Therapy for Geographic Atrophy and Dry Age-Related Macular Degeneration. Biomedicines.

Chicago Style (17th ed.) Citation

Kocab, Andrew J., Marisol Cano, Marianna Bacellar-Galdino, Jeffrey A. Jamison, William J. Brock, David N. Zacks, and James T. Handa. "In Vivo Characterization of ONL1204, a Small Peptide Inhibitor of the Fas Receptor, as a Potential Neuroprotective Therapy for Geographic Atrophy and Dry Age-Related Macular Degeneration." Biomedicines Aug. 2025.

MLA (9th ed.) Citation

Kocab, Andrew J., et al. "In Vivo Characterization of ONL1204, a Small Peptide Inhibitor of the Fas Receptor, as a Potential Neuroprotective Therapy for Geographic Atrophy and Dry Age-Related Macular Degeneration." Biomedicines, Aug. 2025.